Finds association of apoptosis inhibitor of macrophage with disease severity in IgA nephropathy, suggesting potential therapeutic targets.
Background: IgA nephropathy is characterized by mesangial deposits of IgA1-containing immune complex with complement 3 (C3). Our previous study demonstrated that apoptosis inhibitor of macrophage (AIM) plays a critical role in in situ IgA-containing immune complex formation and subsequent complement activation in murine IgA nephropathy. We further evaluated the clinicopathological role of AIM in human IgA nephropathy. Methods: We enrolled 77 patients with IgA nephropathy, 5 patients with thin basement membrane disease as disease controls, and 40 age-matched healthy individuals as healthy controls. We analyzed the association between serum IgM-free AIM (sAIM)/glomerular AIM (gAIM) deposition area and clinicopathological features. Results: sAIM level was higher in patients with IgA nephropathy at diagnosis than in disease and healthy controls (1.02 ± 0.49 µg/mL vs. 0.56 ± 0.19 µg/mL vs. 0.57 ± 0.20 µg/mL), significantly decreased to 0.67 ± 0.44 µg/mL after tonsillectomy and steroid pulse therapy, and was associated with serum IgA (r 2 = 0.23) and IgA–IgG immune complex levels (r 2 = 0.12). gAIM was colocalized with mesangial IgA and high intensity of gAIM was associated with the degree of hematuria (30–49/HPF vs. 10–19/HPF) and acute lesions, including those with Oxford classification scores of endocapillary hypercellularity (E1 3% vs. E0 2%) and crescent formation (C1 3% vs. C0 2%). Furthermore, gAIM deposition was positively correlated with glomerular C3 deposition (r 2 = 0.54). Multivariate Cox regression analysis revealed sAIM as independent predictor of hematuria remission (HR = 1.86, 95% CI= 1.03-3.15). According to Kaplan–Meier analysis, patients with larger reduction of sAIM (≥ 0.45 µg/mL) following tonsillectomy and steroid pulse therapy showed a significantly improved hematuria (6 vs. 9 months). Conclusions: We suggest that IgA nephropathy patients with high sAIM levels have high disease activity and patients with high intensity of gAIM deposition have acute glomerular injuries leading to hematuria.
No takes yet. Share an insight, caveat, or question.
Kato et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: